Peter Mac scientists have developed a simple blood test that can show which men with the most aggressive type of prostate cancer should respond to conventional therapy, and those who need other options.
Peter Mac researchers have been supported by the federal government’s MRFF Stem Cell Therapies Mission to investigate new stem cell-based therapies for diseases including leukemia and vision loss through macular degeneration.
Professor Michael Jefford, Director of the Australian Cancer Survivorship Centre (ACSC) based at Peter Mac, will soon take the helm of the American Society of Clinical Oncology’s Cancer Survivorship Committee.
Two clinical trials aimed at improving survival of people with melanoma and endometrial cancer, led by Peter Mac's A/Prof Shahneen Sandhu and Prof Linda Mileshkin, will receive support from the federal government’s Medical Research Future Fund.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.